feed,title,long_url,short_url
SeekingAlpha,Axcella's NASH treatment AXA1125 gets FDA IND clearance,https://seekingalpha.com/news/3681259,
SeekingAlpha,Bally's pushes Q1 guidance ahead of expectations,https://seekingalpha.com/news/3681258,
SeekingAlpha,Tiziana Life Sciences intends to list Accustem Sciences in the U.S,https://seekingalpha.com/news/3681257,
SeekingAlpha,Zscaler started at Buy as Mizuho says upsides outweigh premium valuation,https://seekingalpha.com/news/3681256,
